Product Information

AMLODIPINE-VALSARTAN 10-160 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3592 per EA under NDC 65862073930. Its NADAC has been published 515 times since Oct 12, 2016.

FDA first approved this application on Apr 22, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-VALSARTAN 10-160 MG

Amlodipine and valsartan
$0.3592per EA

Strength

10; 160 mg/1; mg/1

NDC

65862073930

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206512

FDA Approved

4/22/2016

TE Code

AB

On Market Since

4/22/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN 10-160 MG has been published 515 times since Oct 12, 2016, and over the history we have for it it has declined 36.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3592 per EA
All-time high$0.6405 (Aug 11, 2021)
All-time low$0.3145 (May 22, 2024)
52-week high$0.5174
52-week low$0.3592
Median price$0.5131
Average price$0.5020
Largest weekly change+63.9% (Jun 19, 2024)
Weeks tracked515
Tracking sinceOct 12, 2016

Price History

1W

-6.7%

1M

-6.7%

3M

-23.3%

6M

-26.8%

1Y

-30.6%

3Y

-33.8%

5Y

-37.9%

All

-36.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amlodipine and valsartan market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN 10-160 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 10-160 MG, manufactured by Aurobindo Pharma Limited, is $0.3592 per EA (NDC 65862073930), effective Aug 19, 2026.

How has the price of AMLODIPINE-VALSARTAN 10-160 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 10-160 MG has declined 36.2%. It has been tracked across 515 weekly CMS publications since Oct 12, 2016.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 10-160 MG?

Since Oct 12, 2016, the NADAC for AMLODIPINE-VALSARTAN 10-160 MG has ranged from a low of $0.3145 (May 22, 2024) to a high of $0.6405 (Aug 11, 2021), with a median of $0.5131 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN 10-160 MG?

No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN 10-160 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AMLODIPINE-VALSARTAN 10-160 MG?

AMLODIPINE-VALSARTAN 10-160 MG (NDC 65862073930) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.